|
Drug Monitoring and Toxicology
Citations 531-540 of 565 total displayed.
|
Past content
(since Jan 1997):
|
- Drug Monitoring and Toxicology
Detection of anabolic steroid administration: ratio of urinary testosterone to epitestosterone vs the ratio of urinary testosterone to luteinizing hormone
- Paul J. Perry, John H. MacIndoe, William R. Yates, Shane D. Scott, and Timothy L. Holman
Clin. Chem. 1997; 43: 731-735.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Sweat testing for heroin and metabolites in a heroin maintenance program
- Pascal Kintz, Rudolf Brenneisen, Petra Bundeli, and Patrice Mangin
Clin. Chem. 1997; 43: 736-739.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Microdialysis-HPLC for plasma levodopa and metabolites monitoring in parkinsonian patients
- Sophie Dethy, Marie Aline Laute, Nadège Van Blercom, Philippe Damhaut, Serge Goldman, and Jerzy Hildebrand
Clin. Chem. 1997; 43: 740-744.
[Abstract]
[Full text]
[PDF]
- Clinical Chemistry Forum
Quality systems for unit-use testing devices
- David L. Phillips
Clin. Chem. 1997; 43: 893-896.
[Abstract]
[Full text]
[PDF]
- Laboratory Management
A pragmatic approach to estimating total analytical error of immunoassays
- William A. Sadler, Murray H. Smith, Lynda M. Murray, and John G. Turner
Clin. Chem. 1997; 43: 608-614.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Plasma mitomycin C concentrations determined by HPLC coupled to solid-phase extraction
- Rita Paroni, Cinzia Arcelloni, Elena De Vecchi, Isabella Fermo, Davide Mauri, and Renzo Colombo
Clin. Chem. 1997; 43: 615-618.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Computer-aided identifications of thin-layer chromatographic patterns in broad-spectrum drug screening
- Theodore J. Siek, Corey W. Stradling, Marc W. McCain, and Timothy C. Mehary
Clin. Chem. 1997; 43: 619-626.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Quantitative colorimetric determination of urinary p-aminophenol with an automated analyzer
- Jan F. Van Bocxlaer, Karine M. Clauwaert, Willy E. Lambert, and André P. De Leenheer
Clin. Chem. 1997; 43: 627-634.
[Abstract]
[Full text]
[PDF]
- Drug Monitoring and Toxicology
Interference with testing for lysergic acid diethylamide
- Detlef Ritter, Cherise M. Cortese, Linda C. Edwards, Judith L. Barr, Hyung D. Chung, and Christopher Long
Clin. Chem. 1997; 43: 635-637.
[Abstract]
[Full text]
[PDF]
- General Clinical Chemistry
Positive interference in lithium determinations from clot activator in collection container
- Maureen Sampson, Mark Ruddel, Suzanne Albright, and Ronald J. Elin
Clin. Chem. 1997; 43: 675-679.
[Abstract]
[Full text]
[PDF]
|
|
